Skip to main content
. Author manuscript; available in PMC: 2016 Jun 17.
Published in final edited form as: J Alzheimers Dis. 2016 Feb 6;51(2):451–461. doi: 10.3233/JAD-150991

Table 3.

Multivariable adjusted models depicting the association between 25(OH)D levels and the MRI variables

Model TBV
HPV
WMHV
WMH (extensive)
SCI
β ±SE p β±SE p β ±SE p OR (95% CI) p OR (95% CI) p
25(OH)D as standardized continuous variable
    1 0.14 ± 0.08 0.075 0.003 ±0.002 0.103 −0.03± 0.03 0.212 1.00 (0.84–1.18) 0.973 0.85 (0.71–1.04) 0.108
    2 0.09 ± 0.08 0.268 0.003 ±0.002 0.114 −0.03± 0.03 0.212 1.00 (0.84–1.20) 0.965 0.90 (0.74–1.09) 0.291
    3 −0.002± 0.09 0.984 0.002 ±0.002 0.299 −0.03± 0.03 0.295 1.02 (0.85–1.23) 0.815 0.91 (0.74–1.12) 0.374
25(OH) D <10 ng/mL
    1 −0.34 ±0.29 0.249 0.01 ±0.01 0.033 −0.004± 0.09 0.964 1.00 (0.53–1.89) 0.995 1.34 (0.73–2.48) 0.349
    2 −0.16 ±0.29 0.591 0.01 ±0.01 0.034 −0.03± 0.10 0.778 0.96 (0.50–1.84) 0.896 1.12 (0.60–2.11) 0.721
    3 0.04 ± 0.31 0.889 −0.01 ±0.01 0.058 −0.05± 0.10 0.621 0.90 (0.45–1.81) 0.773 1.18 (0.61–2.27) 0.629
25(OH)D < the cohort-specific 20th percentile
    1 −0.36 ±0.20 0.073 −0.01 ±0.004 0.111 0.01 ±0.06 0.869 0.88 (0.56–1.39) 0.585 1.03 (0.65–1.63) 0.908
    2 −0.23 ±0.20 0.248 −0.01 ±0.004 0.112 0.01 ±0.07 0.829 0.89 (0.56–1.41) 0.619 0.92 (0.57–1.46) 0.717
    3 −0.09 ±0.22 0.687 −0.005 ±0.005 0.296 −0.01± 0.07 0.890 0.88 (0.53–1.43) 0.595 0.89 (0.54–1.47) 0.652
25(OH)D > the cohort-specific 80th percentile
    1 0.28 ± 0.20 0.163 0.002 ±0.004 0.633 −0.07± 0.06 0.277 0.91 (0.59–1.41) 0.676 0.87 (0.53–1.41) 0.557
    2 0.18 ± 0.20 0.362 0.002 ±0.004 0.713 −0.08± 0.07 0.207 0.88 (0.56–1.38) 0.577 0.92 (0.56–1.50) 0.736
    3 0.05 ± 0.21 0.822 −0.000 ±0.004 0.921 −0.08± 0.07 0.226 0.94 (0.59–1.50) 0.798 0.97 (0.59–1.61) 0.904

Bold highlight denotes p< 0.05; HPV, hippocampal volume; SBI, silent cerebral infarcts; TBV, total brain volume; WMHV, white matter hyperintensity volume. Regression coefficients represent the change in mean of each standardized MRI variable per cohort-specific 1-SD increment in 25(OH)D levels; or by the presence of a 25(OH)D concentration <10 ng/mL; < cohort-specific 20th percentile; or > the cohort-specific 80th percentile. Model 1 adjusts for age, gender, and time from vitamin D measurement to MRI. Model 2 adjusts for the addition of vascular risk factors (smoking, hypertension, diabetes, prevalent cardiovascular disease, and homocysteine). Model 3 adjusts for the addition of BMI and vitamin D supplement use.